ANDA 72352, held by Watson Labs. Prazosin Hydrochloride.
As of Nov 16, 2026, ANDA 72352 (Prazosin Hydrochloride), held by Watson Labs, was first approved by FDA on Jan 11, 1989, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 11, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prazosin HydrochlorideEQ 1MG BASE ยท capsule;oral | Prazosin Hydrochloride | Discontinued |
| Jan 28, 1991 | Supplement 6Manufacturing | Approved | None posted |
| Aug 31, 1990 | Supplement 4Manufacturing | Approved | None posted |
| Jun 29, 1990 | Supplement 3Manufacturing | Approved | None posted |
| May 24, 1990 | Supplement 1Labeling | Approved | None posted |
| May 24, 1990 | Supplement 2Manufacturing | Approved | None posted |
| Jan 11, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters